Efficacy of rDiHAVO as a potential vaccine antigen against heartworm infections in a mouse model

Breakthrough infections and incomplete vaccine efficacy drive pathogen immune escape
Minjin Kim, Eunha Shim
PLOS One2 Sep 2026Peer-reviewedCC BY 4.0Full textImmunology Infectious diseasePLOS
Reanalysis of data from ten years of koala chlamydia vaccine trials reveals inherent bias and a lack of protective efficacy
K. J. Chappell, M. D. J. Blyton
bioRxiv2 Sep 2026PreprintAll rights reservedFull textImmunologybioRxiv
Development of an edible vaccine candidate conferring protective efficacy against pneumococcal challenge using conserved PspA epitopes in a murine model
Shahina Akter, Eva Stoger, Tanjina Akhtar Banu +5
Scientific Reports8 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textSystems & synthetic biologyCrossref
Finding the Goldilocks zone: modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
Jacob Berrigan, Stephanie R. Monticelli, Pieter Spealman +15
mBio29 Oct 2026Peer-reviewedPublisher termsFull textMicrobiologyCrossref
Restoring dendritic cell migration: a gut reaction to boost vaccine efficacy in aging
Liwei Zhao, Oliver Kepp, Guido Kroemer +1
OncoImmunology30 Sep 2026Peer-reviewedCC BYFull textImmunologyHAL

Cite

BibTeX

@misc{rajaraman2026efficacy,
  title = {{Efficacy of rDiHAVO as a potential vaccine antigen against heartworm infections in a mouse model}},
  author = {S. Rajaraman and J. Kannan and R. Kalyanasundaram},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.12.750983},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.12.750983v1},
}

RIS

TY  - UNPB
TI  - Efficacy of rDiHAVO as a potential vaccine antigen against heartworm infections in a mouse model
AU  - S. Rajaraman
AU  - J. Kannan
AU  - R. Kalyanasundaram
PY  - 2026
DA  - 2026/09/12
PB  - bioRxiv
DO  - 10.64898/2026.09.12.750983
UR  - https://www.biorxiv.org/content/10.64898/2026.09.12.750983v1
ER  -

Related

Cite